BEIJING (Reuters) – Ping An Insurance (Group) Co of China Ltd saw a 48.9% rise in first-quarter net profit as its investment income improved, China’s largest insurer by market value reported on Wednesday. Profit rose to 38.4 billion yuan ($5.55 billion) for the January-March quarter, it said in a filing. “The domestic economy continued to…
By Ludwig Burger (Reuters) -Switzerland’s Roche said first-quarter sales dropped 7% on falling demand for its COVID-19 therapies and tests, less steep than analysts had expected thanks to strong revenue growth from a new eye drug. Group revenue fell to 15.3 billion Swiss francs ($17.2 billion), the company reported on Wednesday, beating a market view…
By Natalie Grover and Maggie Fick LONDON (Reuters) -GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines. The company reaffirmed its guidance for 2023, saying it expected adjusted operating profit growth to…
By David Milliken LONDON (Reuters) – Britain saw a record number of working days lost due to short-term sickness last year and zero annual growth in economic output per hour worked in the final quarter of 2022, according to official data released on Wednesday. The figures from the Office for National Statistics highlight the challenges…
By Gram Slattery ARLINGTON, Virginia (Reuters) -Former South Carolina Governor Nikki Haley said on Tuesday she was personally against abortion rights but bore no ill will for those who felt differently, in a rare foray by a Republican White House hopeful into one of the more sensitive issues of the 2024 U.S. election campaign. In…
By Raghav Mahobe and Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration said on Tuesday it had approved Biogen Inc’s drug for treating a form of amyotrophic lateral sclerosis (ALS), making it the first available treatment targeting a genetic cause of the disease. The drug, branded as Qalsody, got a green light under the…
By David Shepardson WASHINGTON (Reuters) – A group of nine Republican senators on Tuesday urged the Biden administration to impose sanctions on Huawei Cloud and other Chinese cloud service providers, citing national security concerns, according to a letter seen by Reuters. The previously unreported letter led by Senator Bill Hagerty to the Commerce, State and…
By Sriparna Roy and Bhanvi Satija (Reuters) – Biogen Inc said on Tuesday it will pause or discontinue at least four studies of experimental drugs to focus on more potentially lucrative options including its second Alzheimer’s treatment, Leqembi, in the latest attempt by the new CEO to trim costs. “We made good progress on the…
By Eleanor Whalley (Reuters) – After more than a week of conflict in Sudan, Bandar Dowelbait said his food supplies have nearly run out and he can only go outside to look for drinking water during lulls in fighting which has turned his city into a war zone. Dowelbait, 26, said he wants to leave…
WASHINGTON (Reuters) – U.S. President Joe Biden on Tuesday formally launched his 2024 re-election bid, promising protection against right-wing extremists and highlighting the Jan. 6, 2021, attack on the U.S. Capitol by supporters of then-President Donald Trump. Vowing to “finish this job” of leading America, Biden also vowed to fight efforts to limit women’s healthcare,…
